Allotment Overview
The allotment for the initial public offer (IPO) of Nephrocare Health Services Limited IPO has been finalized on Dec 15, 2025 and is now available to check. Investors can check their allotment status on the issue's registrar Kfin Technologies Limited website, IPO Ji app/website, as well as on the BSE and NSE websites.
Subscription Details
The Nephrocare Health Services Limited IPO was open for subscription between Dec 10, 2025 - Dec 12, 2025 at a price band in the range of ₹438-460 per equity share.
Subscription response by investor category
The Nephrocare Health Services Limited IPO's initial public offering received good responses from investors throughout the three-day bidding. Retail investors' portion was subscribed 2.35 times, while non-institutional investors' quota received 24.77 times subscription. The qualified institutional buyers (QIBs) portion was booked 26.82 times. Overall, the IPO was subscribed 14.08 times.
Check Full Subscription Details about Nephrocare Health Services Limited IPOHow to Check Nephrocare Health Services Limited IPO Allotment Status Online
You can check your IPO allotment status online on the website of the IPO registrar, IPO Ji App/Website, and BSE and NSE websites. You can check the allotment status of the Nephrocare Health Services Limited IPO if you have applied for it.
Steps to Check Nephrocare Health Services Limited IPO Allotment on Kfin Technologies Limited's Website:
Steps to Check Nephrocare Health Services Limited IPO Allotment Status on IPO Ji App/Website:
Allotment status on BSE and NSE
How to Check Nephrocare Health Services Limited IPO Allotment on BSE:
How to Check Nephrocare Health Services Limited IPO Allotment on NSE:
Contact Information
On securing the allotment, you will receive the credit of equivalent shares in your Demat account.
If you have any concerns or queries about the allotment status, contact Kfin Technologies Limited either by phone or email. Investors can call on 04067162222, 04079611000 or send an email with all relevant details to nephrocare.ipo@kfintech.com.